Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
about
Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimersCrystallographic studies of chemically modified nucleic acids: a backward glanceDeterminator-inhibitor pairs as a mechanism for threshold setting in development: a possible function for pseudogenesAntisense-mediated exon skipping: a versatile tool with therapeutic and research applicationsBiochemical prevention and treatment of viral infections - a new paradigm in medicine for infectious diseasesThe influence of locked nucleic acid residues on the thermodynamic properties of 2'-O-methyl RNA/RNA heteroduplexesGene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Fast-track applications: the potential for direct delivery of proteins and nucleic acids to plant cells for the discovery of gene functionTherapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisInvolvement of long noncoding RNAs in diseases affecting the central nervous systemOligonucleotide Therapies: The Past and the PresentDelivery of oligonucleotides with lipid nanoparticlesNMR structure of an -L-LNA:RNA hybrid: structural implications for RNase H recognitionKnocking down disease: a progress report on siRNA therapeuticsA general purpose RNA-cleaving DNA enzymeInhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidineStructure-activity relationships and mode of action of 5-mercapto-substituted oligo- and polynucleotides as antitemplates inhibiting replication of human immunodeficiency virus type 1Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cellsAntisense treatment directed against mutated Ki-ras in human colorectal adenocarcinomaInhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analoguesCholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell cultureInhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonatesPhosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virusAnti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cellsAntisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cellsTherapeutic Potential of Tricyclo-DNA antisense oligonucleotidesApproaches to Validate and Manipulate RNA Targets with Small Molecules in CellsSilencing disease genes in the laboratory and the clinicSolid-Phase Supports for Oligonucleotide SynthesisProgress towards the treatment of Ebola haemorrhagic fever.Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNAThe stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos.Design and applications of modified oligonucleotides.Fast and accurate determination of sites along the FUT2 in vitro transcript that are accessible to antisense oligonucleotides by application of secondary structure predictions and RNase H in combination with MALDI-TOF mass spectrometry.High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotides.Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides.Nuclease-resistant ribozymes decrease stromelysin mRNA levels in rabbit synovium following exogenous delivery to the knee joint.Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.
P2860
Q24547040-D48B840F-D822-4DE6-9428-5EF4C132FB7CQ24608092-0027EA8F-B6CD-47FB-8BEC-5360847454A6Q24632876-56AC2288-8236-4497-951D-3F22F4637C81Q24682555-84848C04-489A-4C1F-9099-42090556DAFFQ24801934-6F40DAF8-7224-46EE-858C-B005920FF4C2Q24812616-9ECE9675-E82C-4B34-A5FE-32E5F72F7EEEQ25256700-CD6838B6-CFD6-4AF2-857E-B60B7E6C0435Q25256817-15C339FC-5C70-459A-BD09-06C49F04AD92Q26782089-A9403276-D132-48E3-98A4-54C09B9DA1ABQ26852160-0047B028-EA1F-43AB-BD60-84927CDAD373Q27002403-62ABA028-FFAE-4030-B3BC-067D60F09E29Q27024646-3071C5BE-E251-4BDD-8309-B9D323BE75A4Q27642301-D3545910-DECA-47E7-B408-280286D9C201Q28082939-D62FBF1C-67C9-4634-951C-DC70480F8D2BQ28315030-DAE1AF72-D6C8-4971-A3E4-9FB33F6E8139Q28316278-B104E41A-B30F-4C9C-B52F-814C8AF7AA28Q28319929-90FFC8FD-893D-4CFD-9C77-9DA7F6D215A2Q28339853-719C54D8-B9D8-4F09-AFB9-457C16CD3001Q28345950-40B2A6C4-9C4F-49FF-85EE-454257B10288Q28355337-9F679626-F429-417B-9CEA-831054912445Q28359555-E850F116-E23A-4682-8E52-76244ABA4A37Q28361132-880D5758-ABCC-4E2F-A3D5-94D9B064AE1FQ28361672-AF3427B9-C478-4571-9E14-56E08CA81ACFQ28367621-4214305F-C483-48A7-A347-D4B0C966BE76Q28369354-C90235E1-F3DB-4FD3-A29B-093378E3D8B0Q28818017-6B78E5B4-51F2-4A07-AEC5-F42A026533EDQ28833658-D887F6F5-586F-4F15-9D74-F4F907781CA7Q29039090-EFA774BD-C6DF-4D95-AA9A-68E18869C7F4Q29999315-A48D5C4C-184D-4B64-8078-89FE3D7D7AD6Q30230272-18FAB507-0A18-4D05-BA45-627B28C7F51FQ30325785-FF96C1B9-FE8C-4796-A47B-20FF593DE74EQ30449973-B155ED22-C8F1-4D46-B416-902FFA385A4DQ30450778-91D5A890-D266-45B7-9CEF-B6C38160F1B1Q30884698-B55B39C9-36F9-4E07-8BD5-B67F61B7136DQ30972411-37CAA3D3-8624-4165-B2E6-8EECDA9C9F39Q33285354-22D5CA4D-B55D-48C5-BDAF-082DBAACFD5EQ33552402-D767713B-0643-44A6-90EC-3333949F4581Q33563974-1C7F17FA-5FB0-4B15-9C7E-2B9F4D522BA2Q33576701-10A16301-913C-40B0-8606-42552B55C87BQ33601089-D8289E58-2C9E-40EA-80B6-C78DAA876935
P2860
Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
description
1978 nî lūn-bûn
@nan
1978 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@ast
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@en
type
label
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@ast
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@en
prefLabel
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@ast
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@en
P2860
P3181
P356
P1476
Inhibition of Rous sarcoma vir ...... specific oligodeoxynucleotide
@en
P2093
M. L. Stephenson
P. C. Zamecnik
P2860
P304
P3181
P356
10.1073/PNAS.75.1.280
P407
P577
1978-01-01T00:00:00Z